Mitral valve prolapse (MVP) affects 2-4% of the general population and remains one of the most frequent indications for valvular surgery. So far, the only gene described in MVP, with an X-linked form of inheritance, is FLNA but only represents a small part of MVP.To this respect, we investigated a french MVP pedigree to uncover new molecular insights associated to the disease. We focus on a family of 5 affected patients characterized by a dysmorphic myxomatous phenotype with 2 operated patients.From 4 MVP patients, we performed a Whole Exome Sequencing screening. From bioinformatics analysis, we focused on rare (MAF<0.1%) functional variants shared by the 4 affected patients. Among 25 variants of interest, 11 were novel. One of them, found ...
Mitral valve prolapse (MVP) is a common cardiovascular abnormality in the United States, occurring i...
International audienceMitral valve prolapse (MVP) is a common cardiac valve disease that affects nea...
The mitral valve prolapse (MVP) affects about 3% of the population and remains one of the most commo...
Mitral valve prolapse (MVP) affects 2-4% of the general population and remains one of the most frequ...
PurposeAlthough a familial distribution has been documented, the genetic aetiology of mitral valve p...
Mitral valve prolapse (MVP) has a prevalence of 2-3% among the population. It involves a heterogeneo...
Nonsyndromic mitral valve prolapse (MVP) is a common degenerative valvulopathy of unknown aetiology ...
AIMS: Mitral valve prolapse (MVP) is a common valvular heart disease with a prevalence of >2% in ...
International audienceNonsyndromic mitral valve prolapse (MVP) is a common degenerative cardiac valv...
AIMS: Mitral valve prolapse (MVP) is a common valvular heart disease with a prevalence of >2% in the...
Mitral valve prolapse (MVP) is a common cardiovascular abnormality in the United States, occurring i...
International audienceMitral valve prolapse (MVP) is a common cardiac valve disease that affects nea...
The mitral valve prolapse (MVP) affects about 3% of the population and remains one of the most commo...
Mitral valve prolapse (MVP) affects 2-4% of the general population and remains one of the most frequ...
PurposeAlthough a familial distribution has been documented, the genetic aetiology of mitral valve p...
Mitral valve prolapse (MVP) has a prevalence of 2-3% among the population. It involves a heterogeneo...
Nonsyndromic mitral valve prolapse (MVP) is a common degenerative valvulopathy of unknown aetiology ...
AIMS: Mitral valve prolapse (MVP) is a common valvular heart disease with a prevalence of >2% in ...
International audienceNonsyndromic mitral valve prolapse (MVP) is a common degenerative cardiac valv...
AIMS: Mitral valve prolapse (MVP) is a common valvular heart disease with a prevalence of >2% in the...
Mitral valve prolapse (MVP) is a common cardiovascular abnormality in the United States, occurring i...
International audienceMitral valve prolapse (MVP) is a common cardiac valve disease that affects nea...
The mitral valve prolapse (MVP) affects about 3% of the population and remains one of the most commo...